All News Rezolute, Inc.

Equities

Market Closed - Nasdaq Other stock markets 01:30:00 19/06/2024 am IST			5-day change	1st Jan Change
3.88 ^USD	+0.78%		-29.20%	+290.93%

14/06	Rezolute Shares Decline After Company Prices $60 Million Public Offering	MT
14/06	Top Premarket Decliners	MT

Rezolute Shares Decline After Company Prices $60 Million Public Offering	14/06	MT
Top Premarket Decliners	14/06	MT
Rezolute Prices $60 Million Stock Offering	14/06	MT
Rezolute Announces Pricing of Public Offering of $60 Million of Common Stock and Pre-Funded Warrants	14/06	GL
Rezolute Starts Equity Offering -- Shares Fall After Hours	14/06	MT
Rezolute Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants	14/06	GL
Rezolute : Corporate Presentation – June 2024	10/06	PU
Sector Update: Health Care Stocks Advance Late Afternoon	06/06	MT
Sector Update: Health Care	06/06	MT
Top Midday Gainers	05/06	MT
Craig-Hallum Initiates Rezolute at Buy Rating With $14 Price Target	04/06	MT
Rezolute to Participate in the Jefferies Global Healthcare Conference	30/05	GL
Traders Cautious Ahead of Fed Minutes, Nvidia Earnings, Stifling US Equity Futures Pre-Bell	22/05	MT
Top Premarket Gainers	22/05	MT
Rezolute : Corporate Presentation – May 2024	22/05	PU
Transcript : Rezolute, Inc. - Special Call	22/05
Rezolute Reports Positive Topline Results in Study of Diabetic Macular Edema Treatment; Shares Surge After Hours	22/05	MT
Rezolute Reports Positive Topline Results from Phase 2 Proof of Concept Study of RZ402 in Patients with Diabetic Macular Edema (DME)	22/05	GL
Rezolute, Inc. Reports Positive Topline Results from Phase 2 Proof of Concept Study of RZ402 in Patients with Diabetic Macular Edema	22/05	CI
Transcript : Rezolute, Inc. - Shareholder/Analyst Call	17/05

No results for this search